How many drugs treat Herpes zoster?

Drug Landscape tracks 6 marketed treatments for Herpes zoster (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/herpes-zoster.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Herpes zoster — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Herpes zoster (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Herpes zoster, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Amenalief	AMENAMEVIR	Maruho			2017-01-01
Valtrex	valaciclovir	GSK	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor		1995-01-01
Famvir	FAMCICLOVIR	Novartis	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]		1994-01-01
Zovirax	ACYCLOVIR	Ligand Pharms	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]	Purine nucleoside phosphorylase	1982-01-01
Aciclovir	Aciclovir	Assistance Publique Hopitaux De Marseille		Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase
ACYC	ACYC	Ligand Pharms		Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Ligand Pharms · 2 drugs in Herpes zoster
Assistance Publique Hopitaux De Marseille · 1 drug in Herpes zoster
GSK · 1 drug in Herpes zoster
Maruho · 1 drug in Herpes zoster
Novartis · 1 drug in Herpes zoster

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Herpes zoster:

Cite this brief

Drug Landscape (2026). Herpes zoster — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/herpes-zoster. Accessed 2026-06-10.

Herpes zoster full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing